TY  - JOUR
AU  - Guerra-Rebollo, Marta
AU  - Nogueira de Moraes, Carolina
AU  - Alcoholado, Cristina
AU  - Soler-Botija, Carolina
AU  - Sanchez-Cid, Lourdes
AU  - Vila, Olaia F
AU  - Meca-Cortes, Oscar
AU  - Ramos-Romero, Sara
AU  - Rubio, Nuria
AU  - Becerra, Jose
AU  - Blanco, Jeronimo
AU  - Garrido, Cristina
PY  - 2018
DO  - 10.1016/j.omto.2018.09.002
SN  - 2372-7705
UR  - http://hdl.handle.net/10668/13133
T2  - Molecular therapy oncolytics
AB  - A preclinical model of glioblastoma (GB) bystander cell therapy using human adipose mesenchymal stromal cells (hAMSCs) is used to address the issues of cell availability, quality, and feasibility of tumor cure. We show that a fast proliferating...
LA  - en
PB  - Cell Press
KW  - HVS-thymidine kinase
KW  - bioluminescence
KW  - cell therapy
KW  - clarity
KW  - extracellular vesicle
KW  - glioblastoma bystander therapy
KW  - in vivo glioblastoma model
KW  - mesenchymal stem cell
KW  - transparent brain
KW  - Glioblastoma
KW  - Thymidine Kinase
KW  - Cytoreduction Surgical Procedures
KW  - Feasibility Studies
KW  - Antineoplastic Agents
TI  - Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms.
TY  - research article
VL  - 11
ER  -